Related Experiment Video
Updated: Mar 30, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Arterial Stiffness and Decline in Kidney Function
Sanaz Sedaghat1, Francesco U S Mattace-Raso2, Ewout J Hoorn3
1Departments of Epidemiology.
Insights
Increased arterial stiffness, measured by pulse pressure and carotid stiffness, is linked to faster kidney function decline and higher chronic kidney disease (CKD) risk. Vascular stiffness may be a target for interventions to slow CKD progression.
Area of Science:
- Nephrology
- Cardiovascular Medicine
- Epidemiology
Background:
- The relationship between arterial stiffness and chronic kidney disease (CKD) requires further elucidation.
- Arterial stiffness indicators may predict kidney function decline.
Purpose of the Study:
- To investigate the association between arterial stiffness indicators and kidney function decline.
- To assess the link between arterial stiffness and incident CKD.
Main Methods:
- The Rotterdam Study cohort (3666 participants) assessed pulse pressure (PP), carotid stiffness, and pulse wave velocity (PWV).
- Genetic risk scores for PP and PWV were created.
- Kidney function decline and incident CKD were evaluated using estimated glomerular filtration rate (eGFR) over 11 years.
- A meta-analysis of population-based studies was performed.
Main Results:
- Higher pulse pressure (PP) and carotid stiffness were significantly associated with steeper annual eGFR decline and increased risk of incident CKD.
- Higher pulse wave velocity (PWV) was associated with a higher risk of incident CKD.
- Meta-analysis confirmed that higher PP and PWV correlated with increased CKD risk.
- A higher PP genetic risk score was linked to faster eGFR decline and higher CKD risk.
Conclusions:
- Elevated arterial stiffness is independently associated with accelerated kidney function decline.
- Vascular stiffness represents a potential therapeutic target for mitigating CKD progression.
Background And Objectives:
The independent link between arterial stiffness and CKD remains unknown. We investigated the association of indicators of arterial stiffness with decline in kidney function.
Design, Setting, Participants, & Measurements:
We studied 3666 participants (mean age =65 years old; 58% women) from the Rotterdam Study. Pulse pressure (PP), carotid stiffness, and pulse wave velocity (PWV) were measured. We created genetic risk scores for PP and PWV. Annual declines in kidney function and incident CKD were assessed using eGFR. To put our findings in context of the literature, we performed a meta-analysis of the available population-based studies.
Results:
After a median (interquartile range) follow-up time of 11 (10.7-11.3) years, 601 participants with incident CKD were recognized. In the model adjusted for age, sex, mean arterial pressure, heart rate, and baseline GFR, each SD higher PP was associated with 0.15-ml/min per 1.73 m(2) steeper annual eGFR decline (95% confidence interval [95% CI], 0.10 to 0.20) and 11% higher risk of incident CKD (95% CI, 1.05 to 1.18). Each SD greater carotid stiffness was associated with 0.08-ml/min per 1.73 m(2) steeper annual eGFR decline (95% CI, 0.04 to 0.13) and 13% higher risk of incident CKD (95% CI, 1.05 to 1.22). Each SD higher PWV was associated with 7% higher risk of incident CKD (95% CI, 1.00 to 1.14). Incorporating our findings in a meta-analysis, each SD higher PP and PWV were associated with 16% (95% CI, 1.12 to 1.21) and 8% (95% CI, 1.03 to 1.14) higher risks of incident CKD. Each SD higher PP genetic risk score was associated with 0.06-ml/min per 1.73 m(2) steeper annual eGFR decline (95% CI, 0.01 to 0.10) and 8% higher risk of incident CKD (95% CI, 1.03 to 1.14). There was no association between PWV genetic risk score and kidney function decline.
Conclusions:
Higher indices of arterial stiffness are associated with steeper decline in kidney function. This suggests that vascular stiffness could be considered as a target for delaying decline in kidney function.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Peripheral Artery Disease I: Introduction
Chronic Kidney Disease I: Introduction
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Hypertension II: Pathophysiology
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

